- This event has passed.
World Orphan Drug Congress
20th April 2017 - 21st April 2017
As a global diagnostic company, we understand the importance of increasing and promoting research into research that is devoted to revolutionising healthcare for those with rare diseases. We are delighted to be exhibiting at this year’s World Orphan Drug Congress in Washington, DC and are looking forward to welcoming you all to booth 510 to discuss the continual research at Randox Biosciences into an array of health concerns worldwide.
Our in-house product development and Central Laboratory service, RCLS, has enabled us to partner globally with the pharmaceutical industry on a broad range of companion diagnostic (CDx) projects. With over 120 FDA/CE marked kits and over 400 RUO biomarker assays, we offer the full package of diagnostic and CDx assay development, optimisation and regulatory approval.
Dr. Claire Huguet, Head of Biomarkers Services at Randox Biosciences will be available at booth 510 along with our Project Manager, Amy Best.
To prearrange a meeting, please contact, firstname.lastname@example.org